Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets
Transfusion Medicine and Hemotherapy · 2024 · 51 (2) · 110-117
DOI: 10.1159/000532130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Medicine and Hemotherapy, online erschienen am 30.08.2023. Verfasst von Stefani Xhaxho und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Primary human blood cells represent an essential model system to study physiology and disease. However, human blood is a limited resource. During healthy donor plateletpheresis, the leukoreduction system chamber (LRSC) reduces the leukocyte amount within the subsequent platelet concentrate through saturated, fluidized, particle bed filtration technology. Normally, the LRSC is discarded after apheresis is completed. Compared to peripheral blood, LRSC yields 10-fold mononuclear cell concentration.
Methods
To explore if those retained leukocytes are attractive for research purposes, we isolated CD3+ T cells from the usually discarded LRSCs via density gradient centrifugation in order to manufacture CD19-targeted chimeric antigen receptor (CAR) T cells.
Results
Immunophenotypic characterization revealed viable and normal CD4+ and CD8+ T-cell populations within LRSC, with low CD19+ B cell counts. Magnetic-activated cell sorting (MACS) purified CD3+ T cells were transduced with CD19 CAR-encoding lentiviral self-inactivating vectors using concentrated viral supernatants. Robust CD19 CAR cell surface expression on transduced T cells was confirmed by flow cytometry. CD19 CAR T cells were further enriched through anti-CAR MACS, yielding 80% CAR+ T-cell populations. In vitro CAR T cell expansion to clinically relevant numbers was achieved. To prove functionality, CAR T cells were co-incubated with the human CD19+ B cell precursor leukemia cell line Nalm6. Compared to unmodified T cells, CD19 CAR T cells effectively eradicated Nalm6 cells.
Conclusion
Taken together, we can show that lymphocytes isolated from LRSCs of plateletpheresis sets can be efficiently used for the generation of functional CAR T cells for experimental purposes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
- Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.
- Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany.
- German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Zitieren
APA
Xhaxho, S., Chen-Wichmann, L., Kreissig, S., Windisch, R., Gottschlich, A., Nandi, S., Schabernack, S., Kohler, I., Kellner, C., Kobold, S., Humpe, A., & Wichmann, C. (2024). Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets. Transfusion Medicine and Hemotherapy, 51(2), 110-117. https://doi.org/10.1159/000532130
Vancouver
Xhaxho S, Chen-Wichmann L, Kreissig S, Windisch R, Gottschlich A, Nandi S, et al. Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets. Transfusion Medicine and Hemotherapy. 2024;51(2):110-117. doi:10.1159/000532130
BibTeX
@article{Xhaxho2024,
author = {Xhaxho, Stefani and Chen-Wichmann, Linping and Kreissig, Sophie and Windisch, Roland and Gottschlich, Adrian and Nandi, Sayantan and Schabernack, Sophie and Kohler, Irmgard and Kellner, Christian and Kobold, Sebastian and Humpe, Andreas and Wichmann, Christian},
title = {Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets},
journal = {Transfusion Medicine and Hemotherapy},
year = {2024},
volume = {51},
number = {2},
pages = {110--117},
doi = {10.1159/000532130}
}
EUVIMED